And or Relapsed-refractory Multiple Myeloma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-08-24
Clinical Trial Update: Safety and Efficacy of Melflufen and Dexamethasone in Relapsed and/or Relapsed-Refractory Multiple Myeloma Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating melflufen plus dexamethasone in relapsed/refractory multiple myeloma; terminated with posted results.